Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00062309 · ClinicalTrials.gov registry record · Phase 3
Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer
A Phase 3 study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 307
- Enrollment target
NCT00062309 is a Phase 3 study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 307 participants.
The verdict
NCT00062309, a Phase 3 study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 307 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays and other sources of radiation to kill tumor cells. It is not yet known which radiation therapy regimen is more effective in treating prostate cancer. PURPOSE: This randomized phase III trial is comparing two different regimens of radiation therapy to see how well they work in treating patients with stage II or stage III prostate cancer.
Interventions
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2002-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00062309
The ClinicalTrials.gov registry entry for NCT00062309 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.
NCT00062309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00062309 about?
NCT00062309 is a clinical study titled "Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays and other sources of radiation to kill tumor cells. It is not yet known which radiation therapy regimen is more effective in treating prostate cancer. PURPOSE: This randomized phase III trial is comparing two different regimens of radiation thera...
What is the current status of trial NCT00062309?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 307 participants. The study started on 2002-06.
What interventions are being tested in trial NCT00062309?
The interventions under investigation include: radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00062309?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.